Radical scavengers for Ménière's disease after failure of conventional therapy: A pilot study

Acta Oto-Laryngologica

Volumn 123, Issue 6, 2003, Pages 697-703

  Takumida, Masaya ^a   Anniko, Matti ^b   Ohtani, Makiko ^c  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

M ni re's disease; Pilot study; Radical scavengers

Indexed keywords

ASCORBIC ACID; GLUTATHIONE; REBAMIPIDE; SCAVENGER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HEARING DISORDER; HUMAN; MALE; MENIERE DISEASE; PILOT STUDY; PRIORITY JOURNAL; TINNITUS; TREATMENT OUTCOME; VERTIGO;

EID: 0042427815     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480310000728a     Document Type: Article

References (18)

1. Söderman A-CH, Bagger-Sjöbäck D, Bergenius J, Langius A. Factors influencing quality of life in patients with Ménière's disease, identified by a multidimensional approach. Otol Neurootol 2002; 23: 941-8.
2. Claes J, Van De Heyning PH. A review of medical treatment for Ménière's disease. Acta Otolaryngol Suppl 2000; 544: 34-9.
3. Colletti V. Medical treatment in Ménière's disease: avoiding vestibular neurectomy and facilitating post-operative compensation. Acta Otolaryngol Suppl 2000; 544: 27-33.
4. Stahle J, Friberg U, Svedberg A. Long-term progression of Menière's disease. Am J Otol 1989; 10: 170-3.
5. Silverstein H, Smouha E, Raleigh J. Natural history vs. surgery for Menière's disease. Otolaryngol Head Neck Surg 1989; 100: 6-16.
6. Friberg U, Stahle J, Svedberg A. The natural course of Meniere's disease. Acta Otolaryngol Suppl (Stockh) 1984; 406: 72-7.
7. Takumida M, Anniko M, Popa R, Zhang DM. Pharmacological models for inner ear therapy with emphasis on nitric oxide. Acta Otolaryngol 2001; 121: 16-20.
8. Duan ML, Ulfendahl M, Layrell G, et al. Protection and treatment of sensorineural hearing disorders caused by exogenous factors: experimental findings and potential clinical application. Hear Res 2002; 69: 169-78.
9. Horner KC, Guilhaume A. Ultrastructural changes in the hydropic cochlea of the guinea pig. Eur J Neurosci 1995; 7: 1305-12.
10. Shinomori Y, Kimura RS. Allopurinol attenuates endolymphatic hydrops in the guinea pig cochlea. ORL J Otorhinolaryngol Relat Spec 2001; 63: 267-71.
11. Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 1995; 113: 181-5.
12. Mizukoshi K, Watanabe Y, Shojaku H, Matsunaga T, Tokumasu K. Preliminary guidelines for reporting treatment results in Meniere's disease - according to Committee of Japan Society for Equilibrium Research. Equilibrium Res Suppl 1995; 11: 80-5.
13. Torok N. Old and new in Ménière's disease. Laryngoscope 1977; 103: 589-93.
14. Arenberg IK, Bayer RF. Therapeutic options in Ménière's disease. Arch Otolaryngol 1977; 103: 589-93.
15. Sha S-H, Schacht J. Antioxidant attenuates free radical formation in vitro and ototoxicity in vivo: D-methionine is a potent protectant. Hear Res 2000; 142: 34-40.
16. Takumida M, Yajin K. Treatment of cisplatin ototoxicity by antioxidant drugs. Pract Otol (Kyoto) 2000; 93: 533-9.
17. Klockhoff I, Lindbloom U, Stahle J. Menière's disease and hydrochlorothiazide - a critical analysis of symptoms and therapeutic effect. Acta Otolaryngol (Stockh) 1967; 63: 347-65.
18. Santos FM, Hall RA, Snyder JM, Hughes LF, Dobie RA. Diuretic and diet effect on Meniere's disease evaluated by the 1985 Committee on Hearing and Equilibrium Guidelines. Otolaryngol Head Neck Surg 1993; 109: 680-9.